This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A COMPARATIVE STUDY OF THE EFFECTS OF SULFANILAMIDE AND ANTIPNEUMOCOCCUS SERUM ON THE COURSE OF EXPERIMENTAL PNEUMOCOCCIC INFECTIONS

EDWIN E. OSGOOD, M.D.

Arch Intern Med. 1938;62(2):181-198.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The pneumococcus was chosen for this study because of the great clinical importance of pneumococcic infections and because the studies that have been published have given conflicting and inconclusive results.

REVIEW OF THE LITERATURE

The vaccine vial technic of culture of human marrow¹ permits quantitative studies of the interaction of living human cells and noxious and therapeutic agents. Studies of the mode of action of sulfanilamide on experimental infections due to beta hemolytic streptococci² indicated that sulfanilamide itself did not kill the organisms but rendered them vulnerable to bactericidal substances present in normal human serum, probably by preventing the formation, or by neutralization, of the toxins or aggressins of the organisms. These studies also indicated that the concentration of sulfanilamide necessary to control hemolytic streptococcic infections in the cultures was about 1: 100,000 instead of 1: 10,000, which had previously been recommended, and that even short periods without . . . [Full Text PDF of this Article]

Author Affiliations
With The Technical Assistance of Inez E. Brownlee, B.A. PORTLAND, ORE.

From the Department of Medicine and the Division of Experimental Medicine, University of Oregon Medical School.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?